Agilon Health (AGL) Receivables - Other (2020 - 2023)

Agilon Health (AGL) has 4 years of Receivables - Other data on file, last reported at $4.6 million in Q4 2023.

• Quarterly Receivables - Other fell 33.33% year-over-year to $4.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $4.6 million (down 33.33% YoY) and the FY2023 annual result came in at $4.6 million, down 33.33% from the prior year.
• Receivables - Other slipped to $4.6 million in Q4 2023, from $6.9 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $10.2 million in Q3 2021 to a low of $500000.0 in Q4 2021.
• A 4-year average of $6.4 million and a median of $6.9 million in 2022 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2021 — Receivables - Other slumped 95.0% — and 2022, when it surged 1280.0%.
• Tracing AGL's Receivables - Other over 4 years: stood at $10.0 million in 2020, then tumbled by 95.0% to $500000.0 in 2021, then surged by 1280.0% to $6.9 million in 2022, then plunged by 33.33% to $4.6 million in 2023.
• The last three Receivables - Other figures came in at $4.6 million (Q4 2023), $6.9 million (Q4 2022), and $500000.0 (Q4 2021), per Business Quant data.